至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Cross-Microbial Protection via Priming a Conserved Immune Co-Receptor through Juxtamembrane Phosphorylation in Plants

Cell Host Microbe. 2019; 
Gong BQ, Guo J, Zhang N, Yao X, Wang HB, Li JF.
Products/Services Used Details Operation
Peptide Synthesis The anti-FLS2 and anti-BAK1 antibodies were raised in rabbits by the Genscript company (Nanjing, China) against the FLS2 C-terminal peptide KANSFREDRNEDREV and BAK1 C-terminal peptide DSTSQIENEYPSGPR, respectively, as previously reported (Chinchilla et al.... The anti- pS282 antibody was raised in rabbit by the Genscript company (Nanjing, China) against the peptide antigen DHAS(pS)TSLQSGGLG, and was used at 1: 1,000 dilution. Get A Quote

摘要

Living organisms can be primed for potentiated responses to recurring stresses based on prior experience. However, the molecular basis of immune priming remains elusive in plants that lack adaptive immunity. Here, we report that bacterial challenges can prepare plants for fungal attacks by inducing juxtamembrane phosphorylation of CERK1, the co-receptor indispensable for signaling in response to the fungal elicitor chitin. This phosphorylation is mediated by BAK1, a co-receptor for signaling in response to multiple elicitors. BAK1 interacts with CERK1, and loss of BAK1 reduces priming phosphorylation of CERK1. Juxtamembrane phosphomimetic mutations of CERK1 confer accelerated chitin responses and fortified fung... More

关键词